APL-9796 / Apollo Therap - LARVOL DELTA

A Randomised, Double-blind, Placebo-controlled, Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Subcutaneous, Ascending Single Doses of AP13 in Healthy Adults (ANZCTR) - P1 | N=39 | Completed | Sponsor: Apollo Therapeutics | Active, not recruiting ➔ Completed

Trial completion • Cardiovascular • Hypertension • Pulmonary Arterial Hypertension • Pulmonary Disease • Respiratory Diseases

ViTAL-PH: A Trial of "APL-9796'' in Adults With Pulmonary Hypertension (clinicaltrials.gov) - P2 | N=48 | Recruiting | Sponsor: Apollo Therapeutics Ltd | Not yet recruiting ➔ Recruiting

Enrollment open • Cardiovascular • Hypertension • Pulmonary Arterial Hypertension • Pulmonary Disease • Respiratory Diseases

ViTAL-PH: A Trial of "APL-9796'' in Adults With Pulmonary Hypertension (clinicaltrials.gov) - P2 | N=48 | Not yet recruiting | Sponsor: Apollo Therapeutics Ltd

New P2 trial • Cardiovascular • Hypertension • Pulmonary Arterial Hypertension • Pulmonary Disease • Respiratory Diseases